玻璃体切除联合滤过手术和MMC治疗无晶状体或人工晶状体眼继发青光眼

Vitrectomy combined with filtering operation and mitomycin C for aphakic and psendophakic glaucoma

目的 :探讨玻璃体切除联合滤过手术和丝裂霉素C (MMC)治疗无晶状体和人工晶状体植入眼继发青光眼的方法和疗效。方法 :对 16例 (16眼 )玻璃体脱入前房的无晶状体和人工晶状体眼继发青光眼进行上述手术 ,术后随访 12～ 2 5月 (平均 16月 )。结果 :术后以不用或需要用局部降眼压药、 6mmHg≤眼压≤ 2 1mmHg为成功标准 ,16眼中 10眼成功 ,占 62 5 0 %。术后 16眼中 11眼的视力与术前相同 ,占 68 75 % ;3眼视力稍有提高 ,占 18 75 %。长期并发症为 1例低眼压。结论 :玻璃体切除联合滤过手术和MMC是治疗无晶状体和人工晶状体眼继发青光眼的一种相对安全有效的方法 ,尤其适应于玻璃体脱入前房的病例。

To study the technique and therapeutic effect of combined pars vitrectomy with filtering operation and mitomycin C for aphakic and psendophakic glaucoma. Methods:The procedure was performed on 16 eyes 16 patients with aphakic or psendophakic glaucoma and vitreous prolapse.Postoperatively,the patients were followed up for 12 to 25 months (mean 16 months).The successful criteria was 6 mmHg≤IOP≤21mmHg with or without local IOP lowering medications. Results:Ten of the eyes were successful (62.50%).Visual ac uity was stable in eleven of 16 eyes (68.75%) and slightly improved in 3 eyes (18.75%).There was one eye that encountered lasting hypotony. Conclusions:The technique of combined pars vitrectomy with filtering operation and mitomycin C is relatively safe and effective in controlling intraocular pressure in eyes with aphakic and psendophakic glaucoma in the presence of vitreous prolapse.